Latest stories on AAPG
Ascentage Pharma’s Lisaftoclax Granted Breakthrough Therapy Designation in China for Treatment-Naïve CLL/SLL
GlobeNewswire74 · bullishproduct/pr
Ascentage Pharma’s Lisaftoclax Granted Breakthrough Therapy Designation in China for Treatment-Naïve CLL/SLL
Business Insider74 · bullishproduct/pr
Ascentage Pharma initiated with an Outperform at William Blair
The Fly63 · neutralanalyst
Ascentage Pharma initiated with a Buy at Citi
The Fly63 · neutralanalyst
Citizens initiates Ascentage Pharma stock with outperform rating
Investing.com Analyst Ratings63 · neutralanalyst
3 Beaten-Down Biotech Stocks With Triple-Digit Upside and Big Catalysts Ahead
MarketBeat67 · bullishanalyst
Ascentage Pharma price target lowered to $33 from $46 at JPMorgan
The Fly34 · bearishanalyst
3 Small-Cap Stocks With Catalysts That Could Put Them in the Spotlight
MarketBeat63 · neutralanalyst
Ascentage Pharma Group International reports 1H results
Seeking Alpha50 · neutralearnings
Ascentage Pharma to Participate in Four Upcoming Investor Conferences
GlobeNewswire55 · neutralgeneral
Ascentage Pharma Group International (AAPG) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Ascentage Pharma Group International H1 Earnings Call Highlights
Yahoo Finance56 · neutralearnings
Ascentage Pharma Group International 2026 Q2 - Results - Earnings Call Presentation
Seeking Alpha50 · neutralearnings
Ascentage Pharma Group International GAAP EPS of -$0.32 beats by $0.23, revenue of $44.5M misses by $7.73M
Seeking Alpha56 · neutralearnings
Ascentage Pharma Reports 2026 Interim Unaudited Financial Results and Provides Business Updates
Business Insider63 · neutralearnings
Ascentage Pharma Reports 2026 Interim Unaudited Financial Results and Provides Business Updates
GlobeNewswire63 · neutralearnings
Ascentage Pharma Corrects Timing for August 19, 2026 Interim Results Webcast
TipRanks50 · neutralgeneral
Ascentage Pharma to Participate in the Evercore 2nd Annual China Biotech Summit
StockTitan55 · neutralgeneral
Apogee Reports Second Quarter 2026 Financial Results and Recent Corporate and Pipeline Updates
Business Insider67 · bullishm&a
CORRECTION: Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026
Business Insider50 · neutralgeneral
Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026
Business Insider50 · neutralgeneral
Ascentage Pharma Appoints Dr. Faiçal Miyara as Chief Business Officer and Jim Ziegler as Chief Commercial Officer
Business Insider50 · neutralgeneral
Ascentage Pharma CEO Dajun Yang Ranked Among Top Small-Molecule Leaders in 2026 Power List
TipRanks55 · neutralgeneral
Ascentage Pharma Chairman and CEO Dr. Dajun Yang Named to The Medicine Maker Power List 2026
Business Insider50 · neutralgeneral
Ascentage Pharma Chairman and CEO Dr. Dajun Yang Named to The Medicine Maker Power List 2026
StockTitan50 · neutralgeneral